Mergers & Acquisitions ·
Profusa, Inc. entered into an Option Agreement on July 31, 2026, granting it the right to acquire G3 Vision Labs and…
NVACWProfusa, Inc.
Profusa, Inc. entered into an Option Agreement on July 31, 2026, granting it the right to acquire G3 Vision Labs and its subsidiaries for up to $30 million in gross proceeds conditions. As consideration for the option, Profusa issued 201,120 shares of common stock and 52,903.566 shares of Series A Non-Voting Convertible Preferred Stock to the sellers. The preferred stock converts into common stock at a ratio of 1:1,000 upon stockholder approval. G3’s estimated 2025 net revenues are approximately $111 million. Profusa also filed a Certificate of Designation for the preferred stock and intends to seek shareholder approval for the conversion and transaction. The company operates in the digital health sector, developing biosensing technologies.